Ovarian Cancer Screening for BRCA1 or BRCA2 Carriers
If you have a mutation in the BRCA1 or BRCA2 gene and wish to delay risk reducing surgery, you should consider the ROCA Test.Learn more from Cancer Research UK.
The ROCA Test is a blood test that determines the risk of a woman having ovarian cancer. The test is intended for women with a mutation in the BRCA1 or BRCA2 gene that confers a high risk of developing ovarian cancer. Women with a BRCA1 or BRCA2 gene mutation are generally recommended to consider surgical removal of their ovaries and fallopian tubes. However, this results in early menopause and affects fertility. Hence many women choose to delay this procedure.
The ROCA Test has been evaluated in long term studies involving more than 8,500 women. The results from these studies show that routine surveillance with the ROCA Test can detect ovarian cancer in 8 out of 10 women when they have no obvious symptoms and with a greater proportion being at an earlier stage than women not undergoing surveillance. This means that if you do develop ovarian cancer, it is more likely that you will have less complicated surgery to remove the tumour and all the visible cancer can be removed.
Understand the risks, limitations and contraindications of the ROCA Test.
Frequently Asked Questions
Have questions about the ROCA Test? Get more answers here.